Q3 2026 Neogen Chemicals Ltd Earnings Call Transcript
Key Points
- Neogen Chemicals Ltd (BOM:542665) reported a 9% year-on-year revenue growth in Q3 FY'26, driven by higher volumes in both organic and inorganic chemical segments.
- The company is on track with its strategic growth initiatives, including the construction of a new plant at Dahesh, expected to be operational by Q1 FY'27.
- Neogen Chemicals Ltd has formed a strategic Indo-Japan alliance with Morita Investment Limited to produce and sell LIPF6 salt globally, enhancing its position in the battery materials market.
- The company has received INR83.48 crores in insurance claims related to a fire incident, with further claims expected to be settled soon, providing financial relief.
- Neogen Chemicals Ltd is poised to benefit from the US 45x tax credits and non-FEOC requirements, positioning it as a strategic global partner in the battery chemicals value chain.
- The company's EBITDA and profit after tax were pressured by transient costs related to the ramp-up of Neogen Ionics and elevated operational expenses due to fire incidents.
- Higher finance costs were incurred due to the reconstruction of the Dahesh plant, impacting profitability.
- There are temporary capacity bottlenecks at the facility, which were mitigated through strategic toll manufacturing arrangements.
- The company faces delays in customer approvals for its battery materials, which could impact the timeline for revenue realization.
- Neogen Chemicals Ltd's inventory and receivables have increased, reflecting challenges in working capital management.
Ladies and gentlemen, good day and welcome to the Q3 FY'26 earnings conference call of Neogen Chemicals Limited. (Operator Instructions)
I now hand the conference over to Mr. Nishid Solanki from CDR India. Thank you and over to you, sir.
Thank you. Good afternoon, everyone, and welcome to News and Chemicals Q3 FY'26 earnings conference call for analysts and investors. Today we are joined by senior members of the management team, including Mr. Anurag Surana, non-executive Chairman, Dr. Haridas Kanani, managing director, and Mr. GropiKrishnan Sarathy, Chief Financial Officer. We will commence the call with opening thoughts from the management team, after which we'll open the floor for your questions.
Before we begin, a standard disclaimer, certain statements made or discussed on today's conference call may be forward-looking. Actual results could vary from these forward-looking statements, and a detailed disclaimer is available in Q3 FY'26 earnings presentation, which has been uploaded on stock exchange
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
